Several studies have been conducted in prostate cancer patients with PSMA-detecting tracers for smaller patient cohorts and meta-analyses of those studies support the potential for this imaging method in prostate cancer [84,85]. The gene discussed is FOLH1; the disease is prostate carcinoma.